Skip to main content
. 2017 Feb 20;206(3):203–215. doi: 10.1007/s00430-017-0494-1

Fig. 3.

Fig. 3

Course of viral load decline and treatment regimens. Viral load declines and treatment regimens of first-line treated patients PV-1–PV-14 and therapy-experienced patients (PV-15–PV-20) are depicted. The courses of pVL and treatment regimens are illustrated for each patient. DRM drug-resistance mutation, LD low drug level, LF lost to follow up before reaching pVL <50